Status:
WITHDRAWN
Bupivacaine Liposomal Injectable Suspension, Pain and Narcotic Use After Elective Orthognathic Surgery
Lead Sponsor:
Boston University
Conditions:
Orthognathic Surgery
Eligibility:
All Genders
18-40 years
Phase:
PHASE4
Brief Summary
This research is being done to determine quantitative and qualitative differences in patients' post-operative pain levels following elective orthognathic surgery after the local administration of a li...
Detailed Description
Participants in Group 1 (study group) will receive ExparelTM (133 mg/10 ml - 4 ml into the maxilla, and 6 ml into the mandible). This will be injected into the soft tissue and gingiva surrounding the ...
Eligibility Criteria
Inclusion
- males and females 18-40 years of age undergoing elective double jaw orthognathic surgery
Exclusion
- pregnancy
- known hypersensitivity to any local anesthetic
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03318757
Start Date
September 1 2020
End Date
December 1 2021
Last Update
June 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Medical Center
Boston, Massachusetts, United States, 02118